- Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia
-
Nency YM, Rahmadi FA, M, Anantyo DT, Farhanah N, Hapsari R, Farida H, Sadhana U, Djagat H, Kristina TN, Juniarto AZ, Puspita M, Sari RM, Bachtiar NS
- KMID: 2534926
- Clin Exp Vaccine Res.
- 2022 Jan;11(1):43-52.
- doi: 10.7774/cevr.2022.11.1.43
Purpose Indonesia, a high populous and the second-highest country in epidemicity of hepatitis B in South-East Asia require maintaining its capacity of monovalent hepatitis B production to keep up with both... -
- CITED
-
- Close
- SHARE
-
- Close
